Want to know about Argatroban Market Insights?

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Formula: C23H36N6O5S

The scope of the Report:

This report focuses on the Argatroban in the global market, especially in North America, Europe and Asia-Pacific, South America, Middle East, and Africa. This report categorizes the market based on manufacturers, regions, type, and application.

In the last several years, a global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, the global capacity of Argatroban reduced to 34786 grams

from 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with an average growth rate of -9% in the coming five years.

Japan is the still the largest supplier of argatroban with the production market share of 35% and the consumption market share of 22% in 2015.

The price of argatroban is relatively expensive. The largest consumers have developed countries with high income. USA occupied a market share of 34%. The second place is Europe, following North America with the consumer market share of 22% in 2015.

Get Sample PDF Of Argatroban Market Report @

https://www.marketreportsworld.com/enquiry/request-sample/11903275

There are only 8 Top manufacturers in the Argatroban Market the list is given below

Pfizer, Inc, SANDOZ, GlaxoSmithKline Plc, fresenius-kabi, Eagle Pharmaceuticals, Inc, Mitsubishi Tanabe Pharma, Teva Pharmaceutical Industries Ltd, WEST-WARD,INC

China has few companies entering the market with a production share of only 8%, and demand cannot be satisfied with supply. Large quantities of argatroban have to be imported.

Initially, compared with hirudin and heparin, the therapeutic dose has little effect on platelet, no antigen, and strong antithrombotic effect. The sale value has reached 190 million USA dollars in 2008. But because of its narrow therapeutic area, uncertain factors on human’s bodies and fierce competition from other substitutes, it sales far less than another thrombin inhibitor. The value reduced to 101 million USA dollars in 2015.

The worldwide market for Argatroban is expected to grow at a CAGR of roughly -14.9% over the next five years, will reach 32 million US$ in 2023, from 84 million US$ in 2017, according to study.

Argatroban is an anticoagulant that is a small molecule direct thrombin inhibitor. In 2000, argatroban was licensed by the Food and Drug Administration (FDA) for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). In 2002, it was approved for use during percutaneous coronary interventions in patients who have HIT or are at risk for developing it. In 2012, it was approved by the MHRA in the UK for anticoagulation in patients with heparin-induced thrombocytopenia Type II (HIT) who require parenteral antithrombotic therapy.

Argatroban is given intravenously and drug plasma concentrations reach steady state in 1–3 hours.Argatroban is metabolized in the liver and has a half-life of about 50 minutes. It is monitored by PTT. Because of its hepatic metabolism, it may be used in patients with renal dysfunction. (This is in contrast to lepirudin, a direct thrombin inhibitor that is primarily renally cleared).

WHAT ARE THE REGIONS ARE COVERED IN THIS REPORT?

Argatroban Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
Have Any Query? Ask Our Expert for Argatroban Market Report @ https://www.marketreportsworld.com/enquiry/pre-order-enquiry/11903275

Argatroban is a kind of "blood thinner" used instead of heparin to prevent blood clots during bound procedures to open up the blood vessels within the heart (e.g., balloon surgical operation, coronary stent placement, transdermic coronary intervention-PCI). it's sometimes used with aspirin. it's additionally wont to treat and forestall harmful blood clots and increase platelets in patients who have had a reaction to polyose (e.g., heparin-induced thrombocytopenia-HIT).Argatroban works by obstruction a particular natural substance (thrombin) that the body uses to make blood clots. Blood clots will cause a heart attack, stroke, gangrene, or cause the opened vessel within the heart to shut make a copy.

What is Uses of Argatroban?

Argatroban is a prescription medication used to treat or stop a grume in patients with a particular condition referred to as heparin-induced thrombocytopenia (HIT). HIT is a complication of treatment with a blood diluent known as heparin that puts patients at high risk for a blood clot.

Argatroban is additionally used to stop blood clots in adult patients with or in danger for HIT who are undergoing percutaneous coronary intervention (PCI), that could be a procedure to open up narrowed or blocked blood vessels that offer blood to the heart.

This medication could also be prescribed for alternative uses. raise your doctor or pharmacist for additional info.

In which class Argatroban Drug classified?

Direct thrombin inhibitors

So What Do We Provide in Argatroban Market Report?

Argatroban market along with Report Research Design:

Argatroban Market Types:

Argatroban Powder
Argatroban Injection
Argatroban Market Applications:

Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
Argatroban Market Historic Data (2013-2017):

Industry Trends:Global Revenue, Status and Outlook.
Competitive Landscape: By Manufacturers, Development Trends.
Product Revenue for Top Players: Market Share, Growth Rate, Current Market Situation Analysis.
Market Segment: By Types, By Applications, By Regions/ Geography.
Sales Revenue: Market Share, Growth Rate, Current Market Analysis.
Argatroban Market Influencing Factors:

Market Environment:Government Policies, Technological Changes, Market Risks.
Market Drivers: Growing Demand, Reduction in Cost, Market Opportunities and Challenges.
Argatroban Market Forecast (2018-2025):

Market Size Forecast:Global Overall Size, By Type/Product Category, By Applications/End Users, By Regions/Geography.
Key Data (Revenue): Market Size, Market Share, Growth Rate, Growth, Product Sales Price
Purchase Argatroban Market Report at $ 3480 (SUL) @

 https://www.marketreportsworld.com/purchase/11903275

There are 15 Chapters to deeply display the global Argatroban market.

Chapter 1, to describe Argatroban Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Argatroban, with sales, revenue, and price of Argatroban, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Argatroban, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Argatroban market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Argatroban sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

About Us:
Marketreportsworld is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.

Contact Info:
Name: Ajay More
Email: Sales@marketreportsworld.com
Organization: marketreportsworld
Phone: +1 408 520 9750/+44 203 239 8187

This release was published on openPR.